Physician profile
Thuy Hua
NPI 1871615328
$849.16
in general payments reported to CMS, 2019-2025
10 companies · $338 in 2025
The $338 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $13.18 · 2022: $155 · 2024: $218 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $556.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $556.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $193.36 | 2024-2025 | Miebo, Xiidra, Lotemax Sm |
| Alcon Vision LLC | $187.57 | 2022-2025 | Eysuvis |
| Novartis Pharmaceuticals Corporation | $124.99 | 2019 | |
| Apellis Pharmaceuticals, INC. | $120.39 | 2024 | Syfovre |
| Rxsight INC | $75.12 | 2024-2025 | Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Mallinckrodt Hospital Products INC. | $42.72 | 2025 | Acthar |
| Glaukos Corporation | $35.05 | 2025 | Idosetr |
| Sight Sciences, INC. | $29.98 | 2022 | |
| Oyster Point Pharma, INC. | $26.80 | 2025 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $13.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thuy Hua listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.